Strides Pharma Science Limited — Important, 22-01-2025: General Updates

Strides Pharma has achieved an impressive ESG score of 76/100 in the S&P Global Corporate Sustainability Assessment (CSA) on its debut submission, placing it in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry. The company's strong performance includes a score of 85/100 in Social, 73/100 in Governance, and 62/100 in Environment, significantly exceeding industry averages. Strides excelled in Customer Relations, achieving a perfect score and marking a commitment to exceptional service and trust. The leadership expressed pride in this achievement, emphasizing an unwavering commitment to sustainability and responsible business practices. This noteworthy performance highlights the company’s efforts to impact stakeholders positively and sets a solid foundation for future ESG initiatives, fostering potential growth opportunities for investors.